ArticleCell & bioscience2023

Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling.

Qi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.